However, the low number of samples, the low quality of clinical studies, the lack of standardized tests and the lack of consensus on the processing of samples, especially in urine, explain the controversy regarding the applicability of soluble alpha klotho as a marker of CKD (55). Here, KL is linked to chronic kidney disease.